McKesson Corporation (MCK)

NYSE: MCK · USD

$959

-8.12 (-0.8%)· Recorded snapshot

Dự phòng tiếng AnhVI

Hiển thị bản gốc tiếng Anh trong khi đang dịch

Báo cáo này chưa được dịch. Hãy làm mới sau vài phút khi hàng đợi dịch xử lý xong.

StockMarketAgent Research · Analyzed 2026-05-13

Our latest published analysis: MCK rated Strong Buy

McKesson Corporation's published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$1,016 / share

Potential value

$1,308 / share

Upside to FV

+40.1%

from $959

Moat

9/10

Wide

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$87.2B
Revenue (ttm)	411B
Net income (ttm)	4.6B
EPS (ttm)	$37.5
Shares out	116.6M
P/E (trailing)	25.6x
P/E (forward)	14.4x
Dividend	$3.76 (0.39%)
Volume	623,059
Beta	0.30

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 411B
Net income (ttm): 4.6B
EPS (ttm): $37.5
P/E (trailing): 25.6x
P/E (forward): 14.4x
Market cap: $87.2B

Item	P1	P2	P3	P4	Trend
Period	2022-03-31	2023-03-31	2024-03-31	2025-03-31	Trend
Revenue	$263.97B	$276.71B	$308.95B	$359.05B	+10.8%
Gross profit	$13.13B	$12.36B	$12.83B	$13.32B	+0.5%
Operating income	$2.11B	$4.88B	$4.04B	$4.62B	+30.0%
Net income	$1.11B	$3.56B	$3.00B	$3.30B	+43.5%
EPS (diluted)	$7.23	$25.03	$22.39	$25.72	+52.7%
EBITDA	$2.87B	$5.49B	$4.68B	$5.26B	+22.4%
R&D	—	—	—	—	—
SG&A	$10.54B	$7.78B	$8.66B	$8.51B	-6.9%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	5T	39.4x	10.8x	101.6%	+6.1%	+28.5%	Bán
ABNB	Airbnb, Inc.	97.8B	37.5x	7.4x	16.8%	+24.4%	+28.5%	Bán
ADBE	Adobe Inc.	97.1B	13.9x	3.7x	57.2%	+11.5%	-30.7%	Mua mạnh
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	Bán
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	Giảm
ALGN	Align Technology Inc.	10.9B	26.6x	2.6x	17.2%	+3.6%	+11.6%	Giảm

Base and Bull scenarios

Bull20%

Price target

$1,307.92

+80.4% from spot

Expansion into higher-margin specialty and oncology services successfully transforms the revenue mix. Operating margins expand, and steady cash flows fuel aggressive buybacks, pushing value to the $1,308 high.

Continued expansion into higher-margin specialty distribution and oncology solutions.
Operating margin expansion as the core business transforms into a higher-margin compounder.
Aggressive share repurchases continue unabated.

Base60%

Price target

$1,016.12

+40.1% from spot

McKesson maintains its dominant oligopoly position. Predictable cash flows support steady share repurchases and dividends. Forward earnings trajectory bypasses WACC anomalies to deliver a $1,016 intrinsic value.

Revenue grows at roughly 7.8% tapering to 4%.
Operating margins remain stable around the 1.4% historical average.
A 15x terminal multiple aligned with peers.

Sensitivity: Ke × terminal growth

Ke ↓ / g →	1.5%	2.0%	2.5%	3.0%	3.5%
3.5%	$1,168	$1,558	$1,561	$1,561	$1,561
4.1%	$892	$1,102	$1,442	$1,561	$1,561
5.1%	$645	$749	$892	$1,102	$1,442
6.1%	$506	$567	$645	$749	$892
7.1%	$491	$491	$506	$567	$645

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E14.5

P25 n/aP50 n/aP75 n/a

Trailing P/E19.2

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC31.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All MCK indicators

Market & fundamental data

Available fields

270

Groups with data

Currency

USD

Showing 270 of 270 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000927653
Company name	McKesson Corporation
Country	United States
Country code	US
CUSIP number	58155Q103
Earnings date	2026-11-04
Earnings time	amc
Employees	43,000
Employees change	-2,000
Employees growth	-4.44%
Enterprise value	$118.4B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	March
Founded	1833
In index	SP500
Industry	Medical Distribution
Is primary listing	Yes
Is SPAC	No
ISIN number	US58155Q1031
Last 10-K release date	2026-05-08
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	1998-01-05
Last stock split type	Forward
Market cap	$111.8B
Market cap category	Large-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$958.91
Price currency	USD
Sector	Healthcare
SIC code	5122
Stock price date	2026-10-28
Symbol	MCK
Tags	pharmaceuticals
U.S. state	Texas
Website	https://www.mckesson.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	23.49x
Average P/E ratio (10Y)	60.65x
Average P/E ratio (3Y)	23.38x
Average P/E ratio (5Y)	23.79x
Earnings yield	3.91%
EV/Earnings	25.96x
EV/EBIT	18.52x
EV/EBITDA	16.86x
EV/FCF	18.58x
EV/Sales	0.29x
FCF / EV yield	5.38%
FCF yield	5.7%
Forward EV/Sales	0.27x
Forward P/E	20.57x
Forward P/S	0.26x
Industry forward P/E	19.16x
Industry P/E	27.41x
Lynch fair value	$261.82
Lynch upside	-72.88%
P/E ratio	25.58x
P/FCF ratio	17.55x
P/OCF ratio	16.43x
P/S ratio	0.27x
PEG ratio	1.63x
Price/EBITDA ratio	15.92x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.57%
EBITDA margin	1.72%
Effective tax rate	17.93%
FCF margin	1.56%
Gross margin	3.63%
Operating margin	1.57%
Pretax margin	1.57%
Profit margin	1.12%
Profit per employee	$106,791
Profitable quarters	18
Profitable years	5
Revenue per employee	$9.6M
ROA	4.74%
ROA (5Y)	4.41%
ROCE	35.81%
ROIC	31.75%
ROIC (5Y)	28.31%
Tax / revenue	0.28%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	50.2%
EPS growth (Q)	-17.6%
EPS growth (QoQ)	-62.48%
EPS growth 10Y	14.56%
EPS growth 3Y	11.82%
EPS growth years	2
FCF growth	6.84%
FCF growth 3Y	11.32%
FCF growth 5Y	12.82%
Gross profit growth	13.52%
Gross profit growth (Q)	12.38%
Gross profit growth 3Y	7.23%
Gross profit growth 5Y	3.96%
Net income growth	45.13%
Net income growth (Q)	-21.68%
Net income growth (QoQ)	-63.5%
Net income growth 3Y	6.99%
Net income growth years	2
OCF growth	4.67%
OCF growth 10Y	3.05%
OCF growth 3Y	10.73%
OCF growth 5Y	11.47%
Operating income growth	24.99%
Operating income growth (Q)	11.71%
Operating income growth 3Y	15.03%
Operating income growth 5Y	13.75%
Revenue growth	8.84%
Revenue growth (Q)	7.72%
Revenue growth (QoQ)	9.43%
Revenue growth 10Y	7.85%
Revenue growth 3Y	13.1%
Revenue growth 5Y	10.88%
Revenue growth quarters	24
Revenue growth years	13

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-437M
Depreciation and amortization	$634M
EBIT	$6.4B
EBITDA	$7.1B
EPS	$37.48
FCF per share	$55.03
Financing cash flow	$-4.2B
Free cash flow	$6.4B
Gross profit	$14.9B
Income taxes	$1.2B
Investing cash flow	$-82M
Net borrowing	$2B
Net cash flow	$2.6B
Net income	$4.6B
Operating income	$6.4B
Revenue	$411B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.81
Book value per share	$-36.55
Debt / EBITDA	1.55
Debt / FCF	1.84
Goodwill	$11.3B
Interest coverage	23.41
Long-term assets	$25.5B
Long-term liabilities	$19.3B
Net cash (debt)	$-6.6B
Net cash / market cap	-5.89%
Net debt / EBITDA	0.94
Net debt / FCF	1.03
Piotroski F-Score	6
Property, plant and equipment	$4.6B
Shareholders' equity	$-1.3B
Tangible book value	$-19.5B
Tangible book value per share	$-168.37
Total assets	$88.3B
Total cash	$5.2B
Total debt	$11.8B
Total liabilities	$89.6B
WACC	5.51%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	4.85
Current assets	$62.8B
Current liabilities	$70.4B
Current ratio	0.89
Inventory turnover	15.43
Net working capital	$-11B
Quick ratio	0.5
Working capital	$-7.5B
Working capital turnover	-54.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.37%
Dividend growth	15.03%
Dividend growth (10Y)	12.13%
Dividend growth (3Y)	14.91%
Dividend growth (5Y)	14.61%
Dividend growth years	18
Dividend payment date	2027-01-04
Dividend payment years	33
Dividend payout frequency	Quarterly
Dividend per share	$3.76
Dividend yield	0.39%
Ex-dividend date	2026-12-01
FCF payout ratio	6.83%
Last dividend	$0.94
Payout ratio	10.03%
Shareholder yield	3.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	497.76%
10Y return CAGR	20.49%
10Y total return	544.98%
150-day SMA	$846.46
15Y price change	1,028.85%
15Y return CAGR	18.4%
15Y total return	1,159.76%
1D price change	-0.84%
1M price change	10.71%
1M total return	10.71%
1W price change	-6.86%
1W total return	-6.86%
1Y price change	18.24%
1Y return CAGR	18.72%
1Y total return	18.7%
20-day SMA	$965.19
200-day SMA	$861.04
20Y price change	1,784.89%
20Y return CAGR	16.69%
20Y total return	2,092.1%
3M price change	12.86%
3M total return	12.98%
3Y price change	114.14%
3Y return CAGR	29.46%
3Y total return	117%
50-day SMA	$916.50
50-day SMA vs 200-day SMA	50over200
52-week high	$1,030.27
52-week high date	2026-10-20
52-week low	$723.68
52-week low date	2026-05-11
5Y price change	372.55%
5Y return CAGR	37.13%
5Y total return	384.89%
6M price change	15.83%
6M total return	16.08%
All-time high	$1,030.27
All-time high date	2026-10-20
All-time low	$15.06
All-time low date	1994-12-09
Average true range (ATR)	$22.14
Average volume	694.6K
Beta (1Y)	-0.2
Beta (2Y)	0.07
Beta (5Y)	0.3
Change from 52-week high	-6.93%
Change from 52-week low	32.51%
Change from all-time high	-6.88%
Change from all-time low	6,269.32%
Change from open	-0.27%
Day's gap	-0.57%
Dollar volume	$597.5M
High price	$970.03
Low price	$954.60
Monthly RSI	64.92
Open price	$961.52
Position in 52-week range	27.93%
Premarket change	-0.52%
Premarket close	$967.02
Premarket price	$961.98
Previous close	$967.02
Price vs 150-day SMA	13.34%
Price vs 20-day SMA	-0.6%
Price vs 200-day SMA	11.42%
Price vs 50-day SMA	4.68%
Relative volume	0.9
RSI	51.69
Sharpe ratio	0.58
Sharpe ratio (3Y)	0.94
Sharpe ratio (5Y)	1.22
Sortino ratio	1.18
Sortino ratio (3Y)	1.64
Sortino ratio (5Y)	2.1
Volume	623.1K
Weekly RSI	61.85
YTD price change	16.96%
YTD total return	17.31%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	116.4M
Float percentage	99.83%
Shares change (QoQ)	-2.85%
Shares change (YoY)	-3.37%
Shares held by insiders	0.05%
Shares held by institutions	92.05%
Shares outstanding	116.6M
Short % of float	1.97%
Short % of shares	1.96%
Short ratio	2.6 days

Deeper analysis on MCK

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this MCK report

What is the latest published MCK stock rating?

McKesson Corporation is shown with Strong Buy in the latest published report, analyzed 2026-05-13. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MCK analysis?

The full latest published report, analyzed 2026-05-13, lives at /stocks/MCK/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for MCK?

The latest published report analyzed 2026-05-13 gives MCK a fair value of USD 1,016 and a potential value of USD 1,308. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the MCK page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-13). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

Strong BuyMCK · Fair value $1,016+40.1%

Read full analysis →

McKesson Corporation (MCK)

Our latest published analysis: MCK rated Strong Buy

Price

Financial snapshot

Fair-value bridge

Latest news · MCK

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All MCK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MCK

Frequently asked questions

Lịch sử xếp hạng

Category	Score	Reading
Valuation	8.5
Management	7.3
Balance Sheet	3.0
Profitability	5.0
Revenue Growth	6.0
Risk Assessment	5.5
Competitive Moat	9.0
Earnings Quality	9.0
Capital Efficiency	6.5